References
- Emmie de W, Neeltje van D, Darryl F, et al. SARS and MERS: recent insights into emerging coronaviruses. Nat Rev Microbiol. 2016;14(8):523–534. doi:10.1038/nrmicro.2016.81
- Kim KH, Tandi TE, Choi JW, et al. Middle East respiratory syndrome coronavirus (MERS-CoV) outbreak in South Korea, 2015: epidemiology, characteristics and public health implications. J Hosp Infect. 2017;95(2):207–213. doi:10.1016/j.jhin.2016.10.008
- World Health Organization. Coronavirus disease (COVID-19) pandemic; 2022. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019. Accessed May 10, 2022.
- Zhang XY, Guo J, Wan X, et al. Biochemical and antigenic characterization of the structural proteins and their posttranslational modifications in purified SARS-CoV-virions of an inactivated vaccine candidate. Emerg Microbes Infect. 2020;9(1):2653–2662. doi:10.1080/22221751.2020.1855945
- Rabinowich L, Grupper A, Baruch R, et al. Low immunogenicity to SARS-CoV-2 vaccination among liver transplant recipients. J Hepatol. 2021;75(2):435–438. doi:10.1016/j.jhep.2021.04.020
- Benotmane I, Gautier-Vargas G, Cognard N, et al. Weak anti-SARS-CoV-2 antibody response after the first injection of an mRNA COVID-19 vaccine in kidney transplant recipients. Kidney Int. 2021;99(6):1487–1489. doi:10.1016/j.kint.2021.03.014
- Zhang YJ, Zeng G, Pan HX, et al. Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomized, double-blind, placebo-controlled, Phase 1/2 clinical trial. Lancet Infect Dis. 2021;21(2):181–192. doi:10.1016/S1473-3099(20)30843-4
- Azzi Y, Bartash R, Scalea J, et al. COVID-19 and solid organ transplantation: a review article. Transplantation. 2021;105(1):37–55. doi:10.1097/TP.0000000000003523
- Azzi Y, Parides M, Alani O, et al. COVID-19 infection in kidney transplant recipients at the epicenter of pandemics. Kidney Int. 2020;98(6):1559–1567. doi:10.1016/j.kint.2020.10.004
- Dumortier J, Duvoux C, Roux O, et al. COVID-19 in liver transplant recipients: the French SOT COVID registry. Clin Res Hepatol Gastroenterol. 2021;45(4):101639. doi:10.1016/j.clinre.2021.101639
- Grupper A, Rabinowich L, Schwartz D, et al. Reduced humoral response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients without prior exposure to the virus. Am J Transplant. 2021;21(8):2719–2726. doi:10.1111/ajt.16615